newscaster

Boost Your Business with Omega Funding Solutions: The Ultimate Third-Party Lender for ERC Refunds

Immediate Cash Flow Available Through Fast, Flexible and Equitable Bridge Loans Omega Accounting Solutions Launches Omega Funding Solutions: New Third-Party Lender Offering Advances on ERC IRVINE, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) – According to August reporting—and corroborated by taxpayers reporting 10–12-month delays for receiving their money—the IRS currently has a backlog of more than…

Read More

Maximizing Relationship Banking and Debt Management: Absa Bank Limited Partners with nCino for Enhanced Success

Absa Bank Limited Selects nCino to Optimize its Relationship Banking Debt Management Business JOHANNESBURG, South Africa, Nov. 01, 2022 (GLOBE NEWSWIRE) nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking and digital transformation solutions for the global financial services industry, today announced that Absa Bank Limited (Absa), a leading African bank, has selected the nCino…

Read More

Unlocking Growth Opportunities: The Increasing Prevalence of Thoracic Disorders Fuels Demand for Thoracic Drainage Devices – A Fact.MR Analysis

Rising Prevalence of Thoracic Disorders Generating Growth Opportunities for Thoracic Drainage Device Manufacturers: Fact.MR Analysis Introduction Thoracic disorders, such as pleural effusions and traumatic pneumothorax, are increasingly common in today’s world. As a result, the demand for thoracic drainage devices is on the rise. According to a recent analysis by Fact.MR, global sales of thoracic…

Read More

Set Sail for Success: Norwegian Cruise Line Holdings to Unveil Third Quarter 2022 Financial Results in Upcoming Conference Call!

Company Invites all NCLH Shareholders to Submit Questions for Management Ahead of Earnings Call MIAMI, Oct. 31, 2022 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (together with NCL Corporation Ltd., “Norwegian Cruise Line Holdings” or the “Company”) announced today it will report third quarter 2022 financial results on Tuesday, November 8, 2022…

Read More

Reviva Pharmaceuticals Shares Exciting Update on Global Enrollment for Pivotal Phase 3 RECOVER Study: A Promising Step Towards Evaluating Brilaroxazine for Schizophrenia Treatment

Reviva Pharmaceuticals Announces Global Enrollment Update for Pivotal Phase 3 RECOVER Study Evaluating Brilaroxazine for Schizophrenia Enrollment ongoing at multiple sites in the US and Europe; site initiation in Asia expected in November 2022 Enrollment on pace, with over 30% enrolled in the United States Topline data for RECOVER evaluating brilaroxazine for schizophrenia expected in…

Read More

Join Vyant Bio at the 2022 CDKL5 Forum, Hosted by the Loulou Foundation on November 7-8, 2022

Vyant Bio’s Human First Drug Discovery Platform Platform and Poster Presentations Progress on CDKL5 Deficiency Disorder (CDD) Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Company’s proprietary central nervous system (CNS) platform integrates machine learning and biology to accelerate…

Read More

Shake It Off: SafeHubs’ Building Sensors Bring Peace of Mind After San Jose’s 5.1 Earthquake

Safehub’s Building Sensors Give Companies Peace of Mind After 5.1 Earthquake in San Jose Building Sensors Significantly Reduce Damage Error: What This Means for Companies & Employee Safety SAN FRANCISCO, Oct. 27, 2022 (GLOBE NEWSWIRE) — Late Tuesday morning, a 5.1 magnitude earthquake occurred near San Jose, California, that could be felt by many. For…

Read More